Aller au contenu
1st Transatlantic exchanges in Immuno-Oncology
The VHL Tumor Suppressor Gene as a Rosetta Stone for Kidney Cancer
cGAS-like receptors reveal new signals controlling innate immunity
Epigenetic control of T cell memory and CAR T cell persistance
Immunogenic cell stress and death
Tumour Macrophage Heterogeneity
Microbiota-centered interventions for the future of immuno-oncology
Engineered NK Cells for Enhanced Cancer Immunotherapy
GPRC5D- and Dual-targeted CAR T cell therapy
Translation control in Melanoma
On the Path to Better Cancer Vaccines
Immune contexture and Immunoscore in the era of cancer immunotherapy
The Biology behind PD-1 checkpoint blockade
